Maarten Ligtenberg, PhD
CEO / Founder

Maarten Ligtenberg, PhD, has more than 10 years of expertise in the IO field, having trained as a postdoctoral fellow at the NCI in the Division of Molecular Oncology and Immunology . He completed his doctoral degree at the Karolinska Institutet (2015) under the supervision of Prof. Rolf Kiessling, for his work on new cancer vaccine strategies as well as novel CAR T cell therapies of solid tumors. During his time in the laboratory of Prof. Peeper at the NCI, he has raised upwards of 1 million Euro in funding from both philanthropic foundations and for-profit entities (such as MSD) to support the IO research programs he has been leading. 

He has been instrumental in setting up a range of IO genetic screening platforms, which have successfully identified several new IO therapeutic targets. Leading to the genesis of Immagene with his co-founders.

Maarten Ligtenberg